Sasco A J
Unité d'épidémiologie analytique, Centre international de recherche sur le cancer et Institut national de la santé et de la recherche médicale, Lyon, France.
Rev Epidemiol Sante Publique. 1994;42(5):385-91.
Iatrogenic risk is a necessary component of any curative medical intervention in medicine. By contrast, its existence is often ignored in public health programmes. The example of breast cancer screening by means of mammography is studied here to describe the type and importance of risks linked to the screening examination itself, but also to the ensuing complementary procedures in order to evaluate the global impact on women's health in the general population. Methods for risk evaluation and the few data available in the literature are reviewed. The aim of the present article is to ensure the respect of principles of ethics in the health interventions directed towards populations considered a priori as being healthy, and to put the case for high quality screening.
医源性风险是医学中任何治疗性医疗干预的必要组成部分。相比之下,其存在在公共卫生项目中常常被忽视。本文以乳腺钼靶筛查乳腺癌为例,描述与筛查检查本身以及后续补充程序相关的风险类型和重要性,以便评估对普通人群中女性健康的总体影响。回顾了风险评估方法和文献中现有的少量数据。本文旨在确保在针对先验地被视为健康的人群的健康干预中遵循伦理原则,并支持高质量筛查。